Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,386 public trials 412 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 229 locations
View Trial Details
Recruiting

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • University of Louisville Louisville, Kentucky, United States
  • Tennessee Oncology, PLLC - Elliston Place Plaza DDU Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 90 locations
View Trial Details
Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917

Conditions
Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • START Los Angeles Los Angeles, California, United States
  • Skin Cancer Institute Englewood, Colorado, United States
  • Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 20 locations
View Trial Details

Related conditions